| Date Filed | Type | Description |
| 08/02/2023 |
4
| Roth David (Chief Medical Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Sold 7,348 shares
@ $3.95, valued at
$29k
|
|
| 07/31/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/04/2023 |
4
| Roth David (Chief Medical Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 623 shares
@ $2.58, valued at
$1.6k
Exercised 2,000 restricted stock units
@ $0 |
|
| 10/11/2022 |
4
| Roth David (Chief Medical Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 49,750 options to buy
@ $6.73, valued at
$334.8k
Granted 37,750 restricted stock units
@ $0 |
|
| 07/11/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/04/2022 |
4
| Roth David (Chief Medical Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 27,281 shares
@ $1.12, valued at
$30.6k
|
|
| 02/17/2022 |
4
| Roth David (Chief Medical Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 125,000 options to buy
@ $1.59, valued at
$198.8k
Granted 80,000 restricted stock units
@ $0
Granted 200,000 restricted stock units
@ $0 |
|
| 02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2018 |
4
| Roth David (Chief Medical Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 75,000 options to buy
@ $10.09, valued at
$756.8k
|
|
| 02/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/29/2016 |
3
| Roth David (Chief Medical Officer) has filed a Form 3 on Syros Pharmaceuticals, Inc. |